Table 1.

Frequencies of GSTM1 and GSTT1 gene deletions in aplastic anemia patients and healthy controls

Gene deletionsGSTM1 (%)GSTT1 (%)GSTM1 and GSTT1 (%)
AA patients (n = 57) 47  (82.5) 41  (71.9) 35  (61.4)  
Odds ratio 3.1* 3.1 3.6 
AA patients with CA (n = 10) 8  (80.0)1-153 10  (100)1-155 8  (80.0)1-153 
Controls (n = 75) 45  (60.0) 34  (45.3) 23  (30.7) 
Gene deletionsGSTM1 (%)GSTT1 (%)GSTM1 and GSTT1 (%)
AA patients (n = 57) 47  (82.5) 41  (71.9) 35  (61.4)  
Odds ratio 3.1* 3.1 3.6 
AA patients with CA (n = 10) 8  (80.0)1-153 10  (100)1-155 8  (80.0)1-153 
Controls (n = 75) 45  (60.0) 34  (45.3) 23  (30.7) 

AA indicates aplastic anemia; CA, chromosomal abnormalities.

*

95% CI, 1.4-7.1 (P = .01).

95% CI, 1.5-6.4 (P = .004).

95% CI, 1.7-7.4 (P = .001).

F1-153

P = .29.

F1-155

P = .048.

or Create an Account

Close Modal
Close Modal